BIIB Revenue Flow Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.
2026-03-31: Revenue $2.48B ; Cost of revenue $661.00M ; Research and development (m) ; Selling, general and administrative $607.30M . 2025-12-31: Revenue $2.28B* ; Cost of revenue $495.50M* ; Research and development (m) ; Selling, general and administrative $682.50M* . 2025-09-30: Revenue $2.53B ; Cost of revenue $674.40M ; Research and development (m) ; Selling, general and administrative $594.80M . 2025-06-30: Revenue $2.65B ; Cost of revenue $605.00M ; Research and development (m) ; Selling, general and administrative $583.80M . Product or service Separate filed amounts; connecting flows are not established. Components and totals may overlap.
BIIB revenue flow Filed amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow. Product And Service Other $242.40M Product $1.92B Royalty $10.00M AVONEX $170.00M Alzheimers Collaboration $63.70M BENEPALI $106.80M BYOOVIZ $100.00K Biosimilars $152.80M Contract Manufacturing And Other Revenue $232.40M EMPAVELI $30.40M FLIXABI $8.10M FUMADERM And ADUHELM $0.00 Fumarate $287.40M IMRALDI $37.80M Interferon $225.10M LEQEMBI Collaboration $63.70M MS Product Revenues $963.30M Other Products $70.80M PLEGRIDY $55.10M QALSODY $31.90M Rare Disease Product Revenue $601.70M Revenuesfromanticd2 0therapeuticprograms $513.50M Royalty Attributed To OCREVUS $381.40M SKYCLARYS $167.90M SPINRAZA $401.90M SYFOVRE $97.40M Specialized Immunology $127.80M TECFIDERA $90.90M Tysabri Product $450.80M VUMERITY $196.50M ZURZUVAE $70.80M Revenue $2.74B Cost of revenue $776.90M Other income, net $3.00M Selling, general & administrative $709.70M Pre-tax income $132.40M Income tax $34.90M Net income $97.50M
Segment Separate filed amounts; connecting flows are not established. Components and totals may overlap.
BIIB revenue flow Filed amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow. Reportable Segment $2.74B Revenue $2.74B Cost of revenue $776.90M Other income, net $3.00M Selling, general & administrative $709.70M Pre-tax income $132.40M Income tax $34.90M Net income $97.50M
Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.
Historical revenue and expense breakdown Revenue and expense 3 month Period end Revenue Cost of revenue Research and development Selling, general and administrative Income tax Net income 2026-03-31 $2.48B $661.00M (m) $607.30M $58.20M $319.50M 2025-12-31 $2.28B* $495.50M* (m) $682.50M* -$7.10M* -$48.80M* 2025-09-30 $2.53B $674.40M (m) $594.80M $90.80M $466.50M 2025-06-30 $2.65B $605.00M (m) $583.80M $109.20M $634.80M 2025-03-31 $2.43B $629.30M (m) $572.50M $70.70M $240.50M 2024-09-30 $2.47B $638.70M (m) $588.40M $62.50M $388.50M 2024-06-30 $2.46B $546.00M (m) $553.80M $115.10M $583.60M 2024-03-31 $2.29B $542.20M (m) $581.50M $71.40M $393.40M 2023-09-30 $2.53B $659.60M (m) $788.20M -$72.90M -$68.10M 2023-06-30 $2.46B $592.70M (m) $548.00M $114.80M $591.60M 2023-03-31 $2.46B $662.80M (m) $605.00M $50.70M $387.90M 2022-09-30 $2.51B $469.50M (m) $563.30M $236.20M $1.13B 2022-06-30 $2.59B $484.00M (m) $572.60M $216.70M $1.06B 2022-03-31 $2.53B $753.90M (m) $634.90M $125.60M $303.80M 2021-09-30 $2.78B $511.80M (m) $654.10M -$25.90M $329.20M 2021-06-30 $2.77B $459.70M (m) $637.30M -$409.10M $448.50M 2021-03-31 $2.69B $478.10M (m) $595.00M $44.20M $410.20M 2020-12-31 $2.85B (m) (m) (m) (m) $357.90M 2020-09-30 $3.38B $449.10M (m) $573.10M $240.80M $701.50M 2020-06-30 $3.68B $411.10M (m) $555.10M $446.10M $1.54B 2020-03-31 $3.53B $454.30M (m) $570.10M $292.00M $1.40B 2019-12-31 $3.67B (m) (m) (m) (m) $1.44B 2019-09-30 $3.60B $430.00M (m) $554.50M $211.30M $1.55B 2019-06-30 $3.62B $476.30M (m) $587.60M $248.10M $1.49B 2019-03-31 $3.49B $602.00M (m) $567.70M $422.50M $1.41B 2018-12-31 $3.53B (m) (m) (m) (m) $946.80M 2018-09-30 $3.44B $460.80M (m) $497.70M $369.80M $1.44B 2018-06-30 $3.36B $421.00M (m) $516.20M $263.70M $866.60M 2018-03-31 $3.13B $446.00M (m) $501.30M $322.50M $1.17B 2017-12-31 $3.31B (m) (m) (m) (m) -$297.40M 2017-09-30 $3.08B $370.00M (m) $433.40M $383.80M $1.23B 2017-06-30 $3.08B $366.20M (m) $429.80M $269.60M $862.80M 2017-03-31 $2.81B (m) (m) $498.70M $239.20M $747.60M 2016-12-31 $2.87B (m) (m) (m) (m) $649.20M 2016-09-30 $2.96B (m) (m) $462.70M $337.00M $1.03B 2016-06-30 $2.89B (m) (m) $492.40M $353.60M $1.05B 2016-03-31 $2.73B (m) (m) $497.30M $356.40M $970.90M 2015-12-31 $2.84B (m) (m) (m) (m) $831.60M 2015-09-30 $2.78B (m) (m) $477.80M $330.10M $965.60M 2015-06-30 $2.59B (m) (m) $491.90M $292.50M $927.30M 2015-03-31 $2.56B (m) (m) $560.40M $281.90M $822.50M 2014-12-31 $2.64B (m) (m) (m) (m) $883.50M 2014-09-30 $2.51B (m) (m) $570.44M $274.77M $856.90M 2014-06-30 $2.42B (m) (m) $576.62M $268.52M $714.50M 2014-03-31 $2.13B (m) (m) $511.67M $178.41M $480.00M 2013-12-31 $1.97B (m) (m) (m) (m) $457.30M 2013-09-30 $1.83B (m) (m) $405.58M $186.10M $487.60M 2013-06-30 $1.72B (m) (m) $431.01M $159.14M $490.70M 2013-03-31 $1.42B $133.75M $284.34M $352.60M $65.51M $426.70M 2012-12-31 $1.42B $133.83M* $345.18M* (m) (m) $292.10M 2012-09-30 $1.39B $139.36M $304.22M $299.63M $131.04M $398.40M 2012-06-30 $1.42B $139.11M $329.56M $301.77M $121.02M $386.80M 2012-03-31 $1.29B $133.20M $355.96M $300.09M $82.15M $302.70M 2011-12-31 $1.33B (m) (m) (m) (m) $300.20M 2011-09-30 $1.31B $123.53M $301.39M $261.40M $127.10M $351.80M 2011-06-30 $1.21B $100.50M $285.64M $266.30M $95.04M $288.00M 2011-03-31 $1.20B $103.11M $293.63M $244.52M $117.47M $294.30M 2010-12-31 $1.22B (m) (m) (m) (m) $240.30M 2010-09-30 $1.18B $95.92M $319.05M $244.16M $75.01M $254.10M 2010-06-30 $1.21B $106.98M $331.68M $262.32M $102.24M $293.40M 2010-03-31 $1.11B $97.06M $307.03M $248.66M $75.31M $217.40M 2009-12-31 $1.13B (m) (m) (m) (m) $305.60M 2009-09-30 $1.12B $93.49M $304.06M $226.75M $113.94M $277.70M 2009-06-30 $1.09B $90.72M $416.45M $220.83M $92.71M $142.80M 2009-03-31 $1.04B $98.20M $279.48M $221.83M $65.22M $244.00M 2008-09-30 $1.09B $107.49M $268.80M $232.82M $114.34M $206.79M 2008-06-30 $993.44M $92.40M $252.26M $245.69M $84.71M $206.63M
Revenue and expense 6 month Period end Revenue Cost of revenue Research and development Selling, general and administrative Income tax Net income 2025-06-30 $5.08B $1.23B (m) $1.16B $179.90M $875.30M 2024-06-30 $4.76B $1.09B (m) $1.14B $186.50M $977.00M 2023-06-30 $4.92B $1.26B (m) $1.15B $165.50M $979.50M 2022-06-30 $5.12B $1.24B (m) $1.21B $342.30M $1.36B 2021-06-30 $5.47B $937.80M (m) $1.23B -$364.90M $858.70M 2020-06-30 $7.22B $865.50M (m) $1.13B $738.20M $2.94B 2019-06-30 $7.11B $1.08B (m) $1.16B $670.60M $2.90B 2018-06-30 $6.49B $867.00M (m) $1.02B $586.20M $2.04B 2017-06-30 $5.89B $750.80M (m) $928.50M $508.80M $1.61B 2016-06-30 $5.62B (m) (m) $989.70M $710.00M $2.02B 2015-06-30 $5.15B (m) (m) $1.05B $574.40M $1.75B 2014-06-30 $4.55B (m) (m) $1.09B $446.94M $1.19B 2013-06-30 $3.14B (m) (m) $783.61M $224.65M $917.42M 2012-06-30 $2.71B $272.31M $685.52M $601.86M $203.17M $689.51M 2011-06-30 $2.41B $203.62M $579.28M $510.82M $212.50M $582.36M 2010-06-30 $2.32B $204.04M $638.71M $510.99M $177.55M $510.88M 2009-06-30 $2.13B $188.92M $695.93M $442.66M $157.93M $386.83M 2008-06-30 $1.94B $193.34M $510.49M $461.52M $167.98M $369.73M
Revenue and expense 9 month Period end Revenue Cost of revenue Research and development Selling, general and administrative Income tax Net income 2025-09-30 $7.61B $1.91B (m) $1.75B $270.70M $1.34B 2024-09-30 $7.22B $1.73B (m) $1.72B $249.00M $1.37B 2023-09-30 $7.45B $1.92B (m) $1.94B $92.60M $911.40M 2022-09-30 $7.63B $1.71B (m) $1.77B $578.50M $2.50B 2021-09-30 $8.25B $1.45B (m) $1.89B -$390.70M $1.19B 2020-09-30 $10.59B $1.31B (m) $1.70B $979.00M $3.64B 2019-09-30 $10.71B $1.51B (m) $1.71B $881.90M $4.45B 2018-09-30 $9.93B $1.33B (m) $1.52B $956.00M $3.48B 2017-09-30 $8.97B $1.12B (m) $1.36B $892.60M $2.84B 2016-09-30 $8.58B (m) (m) $1.45B $1.05B $3.05B 2015-09-30 $7.92B (m) (m) $1.53B $904.50M $2.72B 2014-09-30 $7.06B (m) (m) $1.66B $721.71M $2.05B 2013-09-30 $4.97B (m) (m) $1.19B $410.75M $1.41B 2012-09-30 $4.10B $411.67M $989.74M $901.49M $334.21M $1.09B 2011-09-30 $3.72B $327.14M $880.67M $772.22M $339.61M $934.19M 2010-09-30 $3.50B $299.96M $957.76M $755.15M $252.56M $765.00M 2009-09-30 $3.25B $282.40M $999.99M $669.41M $271.87M $664.50M 2008-09-30 $3.03B $300.83M $779.29M $694.34M $282.32M $576.51M
Revenue and expense 12 month Period end Revenue Cost of revenue Research and development Selling, general and administrative Income tax Net income 2025-12-31 $9.89B $2.40B (m) $2.43B $263.60M $1.29B 2024-12-31 $9.68B $2.31B (m) $2.40B $273.80M $1.63B 2023-12-31 $9.84B $2.53B (m) $2.55B $135.30M $1.16B 2022-12-31 $10.17B $2.28B (m) $2.40B $632.80M $3.05B 2021-12-31 $10.98B $2.11B (m) $2.67B $52.50M $1.56B 2020-12-31 $13.44B $1.81B (m) $2.50B $992.30M $4.00B 2019-12-31 $14.38B $1.96B (m) $2.37B $1.16B $5.89B 2018-12-31 $13.45B $1.82B (m) $2.11B $1.43B $4.43B 2017-12-31 $12.27B $1.63B (m) $1.93B $2.46B $2.54B 2016-12-31 $11.45B $1.48B (m) $1.95B $1.24B $3.70B 2015-12-31 $10.76B (m) (m) $2.11B $1.16B $3.55B 2014-12-31 $9.70B (m) (m) $2.23B $989.90M $2.93B 2013-12-31 $6.93B (m) (m) $1.71B $601.00M $1.86B 2012-12-31 $5.52B $545.49M $1.33B $1.28B $470.55M $1.38B 2011-12-31 $5.05B $466.78M $1.22B $1.06B $444.53M $1.23B 2010-12-31 $4.72B $400.26M $1.25B $1.03B $331.33M $1.01B 2009-12-31 $4.38B $382.10M $1.28B $911.03M $355.62M $970.13M 2008-12-31 $4.10B $401.99M $1.07B $925.30M $365.78M $783.17M 2007-12-31 $3.17B $335.19M $925.16M $776.10M $272.42M $638.17M